FDA Advisory Panel To Evaluate Acetaminophen Pediatric Dosing

FDA's pediatric and nonprescription drugs advisory committees will consider whether the agency should add dosing information for children under 2 years to labels for OTC products containing acetaminophen at a joint meeting May 17-18.